Nicholas Borys
Net Worth

Last updated:

What is Nicholas Borys net worth?

The estimated net worth of Dr. Nicholas Borys is at least $9,968,027 as of 12 Dec 2011. He owns shares worth $69,947 as insider and has received compensation worth at least $9,898,080 in Imunon, Inc..

What is the salary of Nicholas Borys?

Dr. Nicholas Borys salary is $582,240 per year as Executive Vice President & Chief Medical Officer in Imunon, Inc..

How old is Nicholas Borys?

Dr. Nicholas Borys is 66 years old, born in 1959.

What stocks does Nicholas Borys currently own?

As insider, Dr. Nicholas Borys owns shares in one company:

Company Title Shares Price per share Total value
Imunon, Inc. (CLSN) Executive Vice President & Chief Medical Officer 35,687 $1.96 $69,947

What does Imunon, Inc. do?

Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.

CLSN logo
CLSN
Imunon, Inc.
$1.96

Nicholas Borys insider trading

Imunon, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Celsion Corporation Common Stock 5,000 $2 $9,995
Purchase
Warrants to Purchase Common Stock 2,499 N/A N/A
Purchase
Series A Redeemable Convertible Preferred Stock 6 $2.4 $14
Purchase
Celsion Corporation Common Stock 1,650 $3.04 $5,008
Purchase
Common Stock 5,596 $2.5 $13,990
Purchase
Common Stock 404 $2.5 $1,010
Purchase
Common Stock 3,000 $4.1 $12,300

Imunon key executives

Imunon, Inc. executives and other stock owners filed with the SEC:

  • Dr. Khursheed Anwer M.B.A., Ph.D. (65) Executive Vice President & Chief Scientific Officer
  • Dr. Nicholas Borys (66) Executive Vice President & Chief Medical Officer
  • Mr. Jeffrey W. Church CPA, CPA (68) Chief Financial Officer, Executive Vice President & Corporation Sec.
  • Mr. Michael H. Tardugno (74) Executive Chairman, Pres & Chief Executive Officer